Influenza A virus subtype H3N8

From WikiMD's WELLNESSPEDIA

Influenza A virus subtype H3N8 is a subtype of the Influenza A virus that is known to cause illness in birds, horses, and dogs. It is a part of the Orthomyxoviridae family of viruses.

History[edit]

The H3N8 subtype was first identified in horses in the late 1960s. It was later found in dogs in the United States in 2004, marking the first time that the virus had been found in a species other than horses or birds. The Canine influenza outbreak of 2004 was caused by the H3N8 subtype.

Structure and Function[edit]

Like all Influenza viruses, H3N8 is an RNA virus. It has a segmented genome, meaning its genetic material is split into eight separate segments. This allows for genetic reassortment, a process that can lead to the creation of new virus strains.

Transmission[edit]

H3N8 is primarily transmitted through the respiratory route, via coughing or sneezing. It can also be spread through direct contact with infected individuals or contaminated surfaces.

Prevention and Treatment[edit]

Vaccines are available for both equine and canine H3N8. Antiviral drugs, such as oseltamivir, may also be used to treat infections.

See Also[edit]



Infectious diseases – viral systemic diseases
Oncovirus
Immune disorders
Central
nervous system
Cardiovascular
Respiratory system/
acute viral
nasopharyngitis/
viral pneumonia



This Animal disease article is a stub. You can help WikiMD by expanding the page.


This Influenza-related article is a stub. You can help WikiMD by expanding the page.

  • Structure of the Influenza A virus subtype H3N8
    Structure of the Influenza A virus subtype H3N8
  • Transmission pathways of H3N8 virus
    Transmission pathways of H3N8 virus
  • Influenza A virus subtype H3N8
    Influenza A virus subtype H3N8

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Influenza_A_virus_subtype_H3N8&oldid=6311303"